Answer:
Option c. cause pooling of the blood and decreased venous return to the heart
Explanation:
The ACE inhibitors increases the diameter of the blood vessels (vasodilation) that improves the flow of blood. This reduces the work load on the heart. At the time of heart failure, a substance called angiotensin is released. This angiotensin formation is blocked by the ACE inhibitors. Angiotensin is involved in narrowing the blood vessels.
The ACE cause pooling of the blood and decreased venous return to the heart. The ACE inhibitors causes vasodilation that allows decrease in blood pressure. So, there is no increase in arterial pressure, aldosterone and loss of volume. Thus, option C is correct.
I think it would be D hope this helps
1. The RNA that has an amino acid attached to it, and that binds to the codon on the mRNA, is called a tRNA.
tRNA are molecules involved in protein synthesis (translation) and those molecules connect codons from mRNA with the amino acids they encode.tRNA has anticodone that binds to mRNA codone.
2. The process, performed by the ribosome, of reading mRNA and synthesizing a protein is called translation.
Translation is a process of gene expression in which proteins are synthesized (translated from the codons on mRNA).
3. Initiation of translation always happens at the start codon of the mRNA.
Translation process can be divided into three stages: initiation (starting off), elongation (adding amino acids to peptide chain that is going to become protein) and termination (finishing up).
4. Amino acids are attached to tRNA by enzymes called aminoacyl-tRNA synthetase.
These enzymes are part of the elongation stage of translation and they catalyze the adding of amino acids.
5. Termination of translation happens when the ribosome hits a stop codon on the mRNA.
Termination is the stage in which the finished polypeptide chain (future protein) is released from the ribosome.
Glycolysis. <span>This is where one 6-carbon molecule of glucose is broken down into two molecules of the three-carbon</span>
D. A protein catalyst in a living organism
